5-(1-DECYL-1,2,5,6-TETRAHYDROPYRIDIN-3-YL)-3-METHYL-1,2,4-THIADIAZOLE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	YHDPDYGUORLMTC-UHFFFAOYSA-N
Smiles	CCCCCCCCCCN1CCC=C(C1)c2nc(C)ns2
InChI	InChI=1S/C18H31N3S/c1-3-4-5-6-7-8-9-10-13-21-14-11-12-17(15-21)18-19-16(2)20-22-18/h12H,3-11,13-15H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C18H31N3S
Molecular Weight	321.52
AlogP	5.16
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	10.0
Polar Surface Area	57.26
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	22.0

Assay Description	Organism	Bioactivity
Insecticidal activity against Aphis craccivora (cowpea aphid) apterous adults reared on broad bean seedlings followed by compound spraying at 200 ppm assessed as insect mortality measured after 4 days	Aphis craccivora	60.0 %
Insecticidal activity against Nephotettix cincticeps (green rice leafhopper) fourth instar larvae reared on compound pre-treated rice seedlings assessed as insect mortality at 200 ppm measured after 7 days	Nephotettix cincticeps	None
Insecticidal activity against imidacloprid-sensitive Nilaparvata lugens (brown planthopper) fourth-instar larvae reared on compound pre-treated rice seedlings assessed as insect mortality at 200 ppm measured after 7 days	Nilaparvata lugens	30.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2272967
PubChem	76334319

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).